EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Reverse Micelles: The Gateway for Oral (Poly)Peptide Delivery

Marlene Ramona Schmidt, Melanie Lena Ebert iD, Andreas Bernkop-Schnürch iD

Small · 2026-11 · 22 (63)

DOI: 10.1002/smll.76409 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Small, online erschienen am 24.10.2026. Verfasst von Marlene Ramona Schmidt und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Technology, Center For Chemistry and Biomedicine, Institute of Pharmacy, University of Innsbruck, Innsbruck, Austria. Hauptthemen laut MEDLINE: Micelles, Peptides, Drug Delivery Systems. Die Arbeit nennt 104 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Reverse micelles (RM) have played a central role in biotechnology, yet their pharmaceutical use has been constrained by instability, high water content and non‐biocompatible surfactants. Classical wet RM (wRM) contain a discrete aqueous core whose size and solubilization behavior are governed by surfactant packing, hydration level and physicochemical properties of the hydrophobic phase. Although these systems provided insights into nanoconfined environments, their sensitivity to dilution and environment has limited translation into drug delivery. Recent developments renew interest in dry RM (dRM), which reduce internal water to below 1% and rely mainly on interfacial rather than bulk‐like water domains, with electrostatic and non‐covalent interactions contributing to stabilization of highly hydrophilic (poly)peptides (pP). dRMs expand the application space for pP therapeutics, supporting delivery routes requiring low hydration and robust microenvironments. This review integrates RM architecture and outlines performance criteria for oral pP delivery, including high loading capacity, increased pP lipophilicity, protection from enzymatic degradation, enhanced epithelial permeation and favorable safety. In vivo studies demonstrate that dRM achieve comparable or improved oral bioavailability relative to hydrophobic ion pairs or wRM in selected systems, underscoring why RM remain relevant and why maintaining minimal hydration and formulation flexibility are central to unlocking their therapeutic potential.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicellesPeptidesDrug Delivery SystemsAdministration, OralHumansAnimals

Stichwörter der Autor:innen

dry reverse micelleshydration statelipid‐based formulationsoral peptide deliveryreverse micellessurfactant packing parameter

Substanzen

MicellesPeptides

Autor:innen und Institutionen

  • Department of Pharmaceutical Technology, Center For Chemistry and Biomedicine, Institute of Pharmacy, University of Innsbruck, Innsbruck, Austria.

ORCID-Profile: Melanie Lena Ebert, Andreas Bernkop-Schnürch

Zitieren

APA

Ramona Schmidt, M., Lena Ebert, M., & Bernkop-Schnürch, A. (2026). Reverse Micelles: The Gateway for Oral (Poly)Peptide Delivery. Small, 22(63). https://doi.org/10.1002/smll.76409

Vancouver

Ramona Schmidt M, Lena Ebert M, Bernkop-Schnürch A. Reverse Micelles: The Gateway for Oral (Poly)Peptide Delivery. Small. 2026;22(63). doi:10.1002/smll.76409

BibTeX
@article{RamonaSchmidt2026,
  author = {Ramona Schmidt, Marlene and Lena Ebert, Melanie and Bernkop-Schnürch, Andreas},
  title = {Reverse Micelles: The Gateway for Oral (Poly)Peptide Delivery},
  journal = {Small},
  year = {2026},
  volume = {22},
  number = {63},
  doi = {10.1002/smll.76409}
}
Kostenlos starten →